Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.

Enterovirus A71 (EV-A71) infection is a major cause of severe hand, foot and mouth disease (HFMD) in young children. The characteristics of EV-A71 neutralizing antibodies in HFMD patients are not well understood. In this study, we identified and cloned EV-A71-neutralizing antibodies by single cell R...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Lei You, Junbo Chen, Yibing Cheng, Yu Li, Yao-Qing Chen, Tianlei Ying, Lance Turtle, Hongjie Yu
פורמט: Article
שפה:English
יצא לאור: Public Library of Science (PLoS) 2023-06-01
סדרה:PLoS Pathogens
גישה מקוונת:https://doi.org/10.1371/journal.ppat.1011420
_version_ 1827917593060573184
author Lei You
Junbo Chen
Yibing Cheng
Yu Li
Yao-Qing Chen
Tianlei Ying
Lance Turtle
Hongjie Yu
author_facet Lei You
Junbo Chen
Yibing Cheng
Yu Li
Yao-Qing Chen
Tianlei Ying
Lance Turtle
Hongjie Yu
author_sort Lei You
collection DOAJ
description Enterovirus A71 (EV-A71) infection is a major cause of severe hand, foot and mouth disease (HFMD) in young children. The characteristics of EV-A71 neutralizing antibodies in HFMD patients are not well understood. In this study, we identified and cloned EV-A71-neutralizing antibodies by single cell RNA and B cell receptor sequencing of peripheral blood mononuclear cells. From 145 plasmablasts, we identified two IgG1 monoclonal antibodies (mAbs) and six IgM mAbs that neutralized EV-A71. Four of the IgM mAbs harbor germline variable sequences and neutralize EV-A71 potently. Two genetically similar IgM antibodies from two patients have recurrent heavy chain variable domain gene usage and similar complementarity-determining region 3 sequences. We mapped the residues of EV-A71 critical for neutralization through selection of virus variants resistant to antibody neutralization in the presence of neutralizing mAbs. The residues critical for neutralization are conserved among EV-A71 genotypes. Epitopes for the two genetically similar antibodies overlap with the SCARB2 binding site of EV-A71. We used escape variants to measure the epitope-specific antibody response in acute phase serum samples from EV-A71 infected HFMD patients. We found that these epitopes are immunogenic and contributed to the neutralizing antibody response against the virus. Our findings advance understanding of antibody response to EV-A71 infection in young children and have translational potential: the IgM mAbs could potentially be used for prevention or treatment of EV-A71 infections.
first_indexed 2024-03-13T03:30:36Z
format Article
id doaj.art-a09a839b9bee48d2a2a8f4618f83fcf9
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-03-13T03:30:36Z
publishDate 2023-06-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-a09a839b9bee48d2a2a8f4618f83fcf92023-06-24T05:31:19ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742023-06-01196e101142010.1371/journal.ppat.1011420Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.Lei YouJunbo ChenYibing ChengYu LiYao-Qing ChenTianlei YingLance TurtleHongjie YuEnterovirus A71 (EV-A71) infection is a major cause of severe hand, foot and mouth disease (HFMD) in young children. The characteristics of EV-A71 neutralizing antibodies in HFMD patients are not well understood. In this study, we identified and cloned EV-A71-neutralizing antibodies by single cell RNA and B cell receptor sequencing of peripheral blood mononuclear cells. From 145 plasmablasts, we identified two IgG1 monoclonal antibodies (mAbs) and six IgM mAbs that neutralized EV-A71. Four of the IgM mAbs harbor germline variable sequences and neutralize EV-A71 potently. Two genetically similar IgM antibodies from two patients have recurrent heavy chain variable domain gene usage and similar complementarity-determining region 3 sequences. We mapped the residues of EV-A71 critical for neutralization through selection of virus variants resistant to antibody neutralization in the presence of neutralizing mAbs. The residues critical for neutralization are conserved among EV-A71 genotypes. Epitopes for the two genetically similar antibodies overlap with the SCARB2 binding site of EV-A71. We used escape variants to measure the epitope-specific antibody response in acute phase serum samples from EV-A71 infected HFMD patients. We found that these epitopes are immunogenic and contributed to the neutralizing antibody response against the virus. Our findings advance understanding of antibody response to EV-A71 infection in young children and have translational potential: the IgM mAbs could potentially be used for prevention or treatment of EV-A71 infections.https://doi.org/10.1371/journal.ppat.1011420
spellingShingle Lei You
Junbo Chen
Yibing Cheng
Yu Li
Yao-Qing Chen
Tianlei Ying
Lance Turtle
Hongjie Yu
Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
PLoS Pathogens
title Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
title_full Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
title_fullStr Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
title_full_unstemmed Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
title_short Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
title_sort antibody signatures in hospitalized hand foot and mouth disease patients with acute enterovirus a71 infection
url https://doi.org/10.1371/journal.ppat.1011420
work_keys_str_mv AT leiyou antibodysignaturesinhospitalizedhandfootandmouthdiseasepatientswithacuteenterovirusa71infection
AT junbochen antibodysignaturesinhospitalizedhandfootandmouthdiseasepatientswithacuteenterovirusa71infection
AT yibingcheng antibodysignaturesinhospitalizedhandfootandmouthdiseasepatientswithacuteenterovirusa71infection
AT yuli antibodysignaturesinhospitalizedhandfootandmouthdiseasepatientswithacuteenterovirusa71infection
AT yaoqingchen antibodysignaturesinhospitalizedhandfootandmouthdiseasepatientswithacuteenterovirusa71infection
AT tianleiying antibodysignaturesinhospitalizedhandfootandmouthdiseasepatientswithacuteenterovirusa71infection
AT lanceturtle antibodysignaturesinhospitalizedhandfootandmouthdiseasepatientswithacuteenterovirusa71infection
AT hongjieyu antibodysignaturesinhospitalizedhandfootandmouthdiseasepatientswithacuteenterovirusa71infection